 |
 |

Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Terry and colleagues recently demonstrated an association between aspirin use and a reduced incidence of hormone receptorpositive breast cancer.1 We are concerned about how the implied relative change of risk (a 26% decrease; OR, 0.74; 95% CI, 0.60-0.93) is presented to the public without addressing the absolute risk reduction.
To really understand what this statistic means, readers should know that 26% represents the decrease in the risk of breast cancer present in nonaspirin users. Given the study design (a population-based case-control study), the risk of breast cancer overall can be calculated: it is the total number of incident breast cancer cases (2030 originally identified in the Long Island Breast Cancer Study Project2), divided by the population at risk (1 021 348 women aged 20 years and older in Nassau and Suffolk counties, New York, US Census 1997). Based on the odds ratio and knowing the proportion of . . . [Full Text of this Article]
Steven Woloshin, MD, MS
steven.woloshin@dartmouth.edu
Lisa M. Schwartz, MD, MS
VA Outcomes Group White River Junction, Vt
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
Patricia G. Moorman
JAMA. 2004;292(12):1426.
EXTRACT
| FULL TEXT
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer RiskReply
Mary Beth Terry, Marilie Gammon, and Alfred I. Neugut
JAMA. 2004;292(12):1427.
EXTRACT
| FULL TEXT
|